Total Payments
$7,817
2024 Payments
$932.23
Companies
43
Transactions
476
Medicare Patients
2,098
Medicare Billing
$171,911
Payment Breakdown by Category
Food & Beverage$7,817 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,817 | 476 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,412 | 84 | $0 (2024) |
| Novo Nordisk Inc | $945.54 | 60 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $760.76 | 48 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $639.44 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $418.91 | 28 | $0 (2024) |
| Lilly USA, LLC | $411.46 | 25 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $411.40 | 27 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $386.25 | 23 | $0 (2024) |
| ABBVIE INC. | $385.74 | 20 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $320.16 | 25 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $932.23 | 48 | PFIZER INC. ($188.30) |
| 2023 | $689.48 | 34 | Novo Nordisk Inc ($145.83) |
| 2022 | $1,810 | 110 | PFIZER INC. ($336.38) |
| 2021 | $1,251 | 77 | PFIZER INC. ($232.62) |
| 2020 | $183.01 | 13 | PFIZER INC. ($59.71) |
| 2019 | $1,046 | 71 | Novartis Pharmaceuticals Corporation ($283.82) |
| 2018 | $697.12 | 46 | PFIZER INC. ($197.47) |
| 2017 | $1,209 | 77 | AstraZeneca Pharmaceuticals LP ($183.36) |
All Payment Transactions
476 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Biological | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Biological | ||||||
| 07/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 529 | 1,031 | $222,925 | $51,015 |
| 2022 | 9 | 583 | 1,196 | $229,080 | $55,825 |
| 2021 | 5 | 509 | 846 | $152,025 | $38,934 |
| 2020 | 4 | 477 | 721 | $125,961 | $26,136 |
Total Patients
2,098
Total Services
3,794
Medicare Billing
$171,911
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 147 | 243 | $68,299 | $14,995 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 144 | 259 | $47,402 | $10,711 | 22.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 30 | 223 | $36,828 | $7,797 | 21.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 54 | 84 | $18,420 | $4,602 | 25.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 33 | 35 | $14,356 | $3,404 | 23.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 35 | 37 | $8,892 | $2,246 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 53 | $11,477 | $2,223 | 19.4% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 16 | 17 | $4,182 | $1,698 | 40.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 14 | 14 | $5,354 | $1,683 | 31.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 15 | 66 | $7,714 | $1,655 | 21.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2022 | 75 | 401 | $57,793 | $14,508 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 153 | 241 | $63,538 | $13,528 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 153 | 291 | $49,797 | $11,986 | 24.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 33 | 33 | $11,816 | $4,087 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 68 | $13,486 | $3,653 | 27.1% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 24 | 25 | $9,804 | $2,450 | 25.0% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 31 | 32 | $7,356 | $1,765 | 24.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 24 | 32 | $6,662 | $1,673 | 25.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2022 | 20 | 54 | $5,710 | $1,417 | 24.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2022 | 16 | 19 | $3,119 | $758.49 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 202 | 352 | $57,271 | $14,671 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 143 | 212 | $53,006 | $11,702 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 47 | 47 | $15,857 | $5,843 | 36.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Facility | 2021 | 56 | 168 | $16,933 | $4,053 | 23.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 36 | $6,265 | $1,894 | 30.2% |
About Dr. William Jeffrey, MD
Dr. William Jeffrey, MD is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285620385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Jeffrey, MD has received a total of $7,817 in payments from pharmaceutical and medical device companies, with $932.23 received in 2024. These payments were reported across 476 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,817).
As a Medicare-enrolled provider, Jeffrey has provided services to 2,098 Medicare beneficiaries, totaling 3,794 services with total Medicare billing of $171,911. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Charleston, WV
- Active Since 09/23/2005
- Last Updated 12/27/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285620385
Products in Payments
- ELIQUIS (Drug) $1,038
- ENTRESTO (Drug) $565.17
- FARXIGA (Drug) $336.66
- Ozempic (Drug) $334.69
- TRELEGY ELLIPTA (Drug) $281.39
- UBRELVY (Drug) $242.41
- JANUVIA (Drug) $238.96
- TRULICITY (Drug) $186.86
- JARDIANCE (Drug) $185.51
- CHANTIX (Drug) $175.59
- SOLIQUA 100/33 (Biological) $157.65
- XIFAXAN (Drug) $153.14
- Saxenda (Drug) $153.10
- XARELTO (Drug) $152.86
- TOUJEO (Biological) $137.15
- BREZTRI (Drug) $136.45
- Wegovy (Drug) $130.10
- Myrbetriq (Drug) $124.56
- LEQVIO (Drug) $115.48
- VRAYLAR (Drug) $103.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Internal Medicine $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Internal Medicine $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Internal Medicine $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Internal Medicine $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518
Internal Medicine $202,518